INTRODUCTION
============

Peroxidasins are members of the peroxidase family with extracellular matrix (ECM) motifs in addition to peroxidase activity. The extracellular motifs contain leucine-rich repeats (LRR) and immunoglobulin-like domains, which are involved in protein-protein interaction and cell-cell attachment. The first peroxidasin was discovered in *Drosophila* in 1994 with potential functions proposed in ECM consolidation, phagocytosis, and pathogen defense ([@b13-molce-38-8-729]); however, few studies have researched these roles *in vivo* ([@b6-molce-38-8-729]; [@b16-molce-38-8-729]). Recently, Gotenstein *et al* reported that peroxidasin PXN-2 is involved in ECM consolidation in *Caenorhabditis elegans* (*C. elegans*). PXN-2 is essential for muscle-epidermal attachment during embryogenesis and the maintenance of basement membrane integrity at later stages of development ([@b6-molce-38-8-729]) by mediating sulfilimine bonds to reinforce the collagen IV network ([@b5-molce-38-8-729]). Moreover, this study suggested that PXN-2 could have a negative relationship with another peroxidasin, PXN-1 ([@b6-molce-38-8-729]).

Our previous study has shown GABAergic neuronal defects in *pxn-1* mutants during neuronal development ([@b11-molce-38-8-729]). Moreover, it has been speculated that *pxn-1* was involved in the maintenance of neuronal integrity with age because *pxn-1* is expressed throughout the lifespan of *C. elegans* ([@b11-molce-38-8-729]). There has been controversy regarding neuron deterioration in aging; however, recent studies have shown age-dependent neuronal defects, such as misshapen neuronal soma, extra neurite branching, axon beading, blebbing, bubble-like lesions, and wavy processes in *C. elegans* ([@b4-molce-38-8-729]; [@b14-molce-38-8-729]; [@b17-molce-38-8-729]; [@b18-molce-38-8-729]). Age-related morphology defects are more prominent in *mec-1* and *mec-5* mutants, which are involved in nerve attachment, than in other mechanosensory-related mutants ([@b14-molce-38-8-729]). In addition, the ECM component can stimulate or inhibit neuronal regeneration in the central nervous system ([@b3-molce-38-8-729]); therefore, ECM structure integrity might contribute to both neuronal development and aging. PXN-2 is involved in ECM consolidation during embryogenesis in *C. elegans* and PXN-1 mutants show neuronal defects during neuronal development; therefore, it is likely that peroxidasins play a role in neuronal maintenance and aging through the regulation of ECM integrity. In the present study, we investigated the relationship between *pxn-1* and *pxn-2* in neuronal development and aging in *C. elegans*.

MATERIALS AND METHODS
=====================

Strains and constructs to observe neuronal defects
--------------------------------------------------

Wild type Bristol N2 strain, *pxn-1*(*ok785*) deletion mutant, CZ1200 *juIs76* (*Punc*-*25::gfp,* a GABAergic motor neuron marker) ([@b7-molce-38-8-729]), and CZ10175 *zdIs5* (*Pmec-4::gfp*, a mechanosensory neuron marker) were obtained from the *Caenorhabditis* Genetics Center (CGC), at the University of Minnesota. *C. elegans* were cultured according to published protocols ([@b2-molce-38-8-729]).

The 7.2 kb of *pxn-1* and 7 kb of *pxn-2* genomic DNAs were amplified by polymerase chain reaction (PCR) and inserted to the Fire vector (pPD95.77). For overexpressing constructs, approximately 3 kb of the 5′-upstream region of *pxn-1* and 2.2 kb upstream of *pxn-2* were used in this study. The constructs were *Ppxn-1::pxn-1::GFP* and *Ppxn-2::pxn-2::mCherry* (*gfp* of the vector was replaced by *mCherry*). For ectopic overexpression, a heat shock promoter from the Fire vector (pPD49.83) was used to construct to *Phs::pxn-1::GFP*, *Phs::pxn-2::mCherry*. Microinjection was performed as previously described ([@b12-molce-38-8-729]) and the plasmid pRF4 containing a dominant gene (*rol-6*) was co-injected with the constructs into *juIs76* (*Punc-25::gfp*) worms. For ectopic overexpression, the transgenic worms were subjected to heat shock at 30°C for 1.5 h every 12 h.

For RNAi bacterial feeding constructs, the *pxn-2* genomic DNA (1.4kb, cut by *Bgl*II and *Kpn*I) was inserted into the Fire feeding vector (L4440). The RNAi constructs were introduced to HT115(DE3) bacteria. The feeding experiments were performed as described in [@b8-molce-38-8-729].

We scored an individual adult worm as a single neuronal defect when it displayed at least one defect, such as incorrect handedness, breakage, tangling, branching, or defasciculation ([@b11-molce-38-8-729]). All observations were conducted under a fluorescent microscope (80i-DS-Fi1, Nikon).

Imaging and quantification of neuronal aging
--------------------------------------------

*zdIs5* and *zdIs5;pxn-1* (*pxn-1* mutants crossed with *zdIs5*) worms were treated with *pxn-2* RNAi bacteria or empty vector (L4440) bacteria. They were cultured and observed for imaging or quantification of aged neurons under the fluorescence microscope.

Short-term associative memory assay
-----------------------------------

N2 with *gfp*RNAi, pxn-1 with *gfp*RNAi, N2 with *pxn-2* RNAi, and *pxn-1* with *pxn-2* RNAi worms were cultured as described above before the memory assay was conducted. The worms were washed in M9 buffer 3--4 times. After starvation at room temperature for 1 h, worms were transferred to conditioning plates that provided HT115 (DE3) as food and 10% butanone and incubated for 1h at room temperature. The worms were then transferred to a normal growth plate colonized with HT115(DE3) alone and incubated for 1 h. After incubation, the animals were transferred to assay plates that were marked and spotted as origin, 10% butanone and 95% ethanol spots according to the protocols ([@b1-molce-38-8-729]; [@b9-molce-38-8-729]; [@b10-molce-38-8-729]). After 1 h of incubation, the worms in each spot were counted. The Chemotaxis Index (CI) was calculated as CI = (\[n~Butanone~\] - \[n~EtOH~\])/(\[Total - nOrigin\]).

RESULTS AND DISCUSSION
======================

*pxn-1;pxn-2* double overexpression compensates the neuronal defects in *pxn-1* single overexpression during neuronal development
---------------------------------------------------------------------------------------------------------------------------------

Overexpression of *pxn-1* in worms results in more prominent neuronal defects during development than in *pxn-1* mutants ([@b11-molce-38-8-729]); therefore, we used *pxn-1* overexpressing worms with either its own promoter or a heat shock promoter to assess neuronal defects ([Figs.1A and 1B](#f1-molce-38-8-729){ref-type="fig"}). Consistent with our previous study, *pxn-1* overexpression (*Ppxn-1::pxn-1*) resulted in increased axonal defects when compared with control worms (74 and 36%, respectively; [Fig. 1A](#f1-molce-38-8-729){ref-type="fig"}). *pxn-2* overexpressing worms (*Ppxn-2::pxn-2*) showed slightly increased defects (44%; [Fig. 1A](#f1-molce-38-8-729){ref-type="fig"}). The overexpression of both *pxn-1* and *pxn-2* (*Ppxn-1::pxn-1*+*Ppxn-2::pxn-2*) attenuated the neuronal defects when compared with *pxn-1* overexpression alone (47%; [Fig. 1A](#f1-molce-38-8-729){ref-type="fig"}). There was a 45% recovery of neuronal defects in *pxn-1*;*pxn-2* double overexpressing worms when compared with *pxn-1* overexpressing worms. These results were replicated using the ectopic overexpressing animals, *Phs::pxn-1*, *Phs:: pxn-2*, and *Phs::pxn-1 + Phs::pxn-2* ([Fig. 1B](#f1-molce-38-8-729){ref-type="fig"}). The recovery pattern of double overexpressing animals was similar between ectopic and *cis*-overexpression, although the rate differed (45% and 21% in *cis*- and ectopic overexpression, respectively). These results suggested that *pxn-1* has an antagonistic relationship with *pxn-2* in neuronal development, which is consistent with the results of [@b6-molce-38-8-729].

*pxn-1* deletion mutation slows the progression of neuronal aging
-----------------------------------------------------------------

Our previous study suggested that *pxn-1* may be involved in neuronal maintenance with age ([@b11-molce-38-8-729]). In addition, recent studies have demonstrated that dopaminergic, GABAergic motor, and mechanosensory neurons undergo morphological changes during aging, including soma outgrowth, ectopic neurite branching, axon beading, lesioning, blebbing, and wavy process development ([@b14-molce-38-8-729]; [@b17-molce-38-8-729]; [@b18-molce-38-8-729]). Mechanosensory neurons are advantageous because they can be easily observed and are well-studied ([@b4-molce-38-8-729]); therefore, we chose touch receptor neurons, anterior lateral microtubule cells (ALM), and posterior lateral microtubule cells (PLM) to investigate neuronal aging. The morphology of touch neurons was observed during aging in controls, *pxn-1* mutants, *pxn-2 RNAi* worms, and *pxn-1;pxn-2 RNAi* worms by using the *zdIs5*(*Pmec-4::gfp*) background. Control worms (*zdIs5*) presented intact ALMs and PLMs at the adult stage (day 1; [Figs. 2A and 2B](#f2-molce-38-8-729){ref-type="fig"}). Representative images of ALM outgrowth on day 10 and day 15 are shown in [Figs. 2C and 2D (arrow)](#f2-molce-38-8-729){ref-type="fig"}. [Figures 2C and 2E](#f2-molce-38-8-729){ref-type="fig"} represent the wavy processes of PLMs on day 10 and day 15 (arrowhead). As shown in [Fig. 2](#f2-molce-38-8-729){ref-type="fig"}, the PLM wavy phenotype was observed more frequently and severely on day 15 than day 10; therefore, this deteriorating phenotype was correlated with aging. To compare neuronal aging among the genotypes, we quantified neuronal defects, such as outgrowth and wavy processes on days 1, 5, 10, and 15 ([Figs. 2F and 2G](#f2-molce-38-8-729){ref-type="fig"}). On day 1, there were no significant differences in neuronal defects in all genotypes ([Figs. 2F and 2G](#f2-molce-38-8-729){ref-type="fig"}); they all contained relatively healthy neurons. As their age progressed, neuronal outgrowth and the frequency of wavy processes increased in all genotypes. In particular, all genotypes showed a sharp increase in ALM outgrowth to ≥ 20% from days 1 to 5, then the rate of increase slowed ([Fig. 2F](#f2-molce-38-8-729){ref-type="fig"}). Considering the short life span of *C. elegans* (2--3 weeks), 53% neuronal outgrowth by day 15 in control worms was expected. *pxn-1* mutants showed consistently lesser neuronal outgrowth throughout the aging process when compared with control worms ([Fig. 2F](#f2-molce-38-8-729){ref-type="fig"}). By contrast, the neuronal outgrowth rate of *pxn-2 RNAi* worms was similar to that of control worms throughout the aging process. Deficient worms with both *pxn-1* and *pxn-2* (*pxn-1;pxn-*2) also showed an outgrowth frequency at the control level during aging, further confirming an antagonistic relationship between *pxn-1* and *pxn-2*. There was a similar pattern found with an additional indicator of neuronal aging, PLM wavy processes ([Fig. 2G](#f2-molce-38-8-729){ref-type="fig"}). The increase in wavy processes was continued to day 15 steadily. Consistent with the ALM outgrowth results, *pxn-1* mutant animals showed less wavy neurons when compared with control worms. The frequency of wavy neurons in *pxn-2* RNAi and *pxn-1*;*pxn-2* RNAi animals was not significantly different from control worms at any time-point ([Fig. 2G](#f2-molce-38-8-729){ref-type="fig"}). These results suggested that *pxn-1* mutants showed a slower progression of neuronal aging. Moreover, the restored phenotypes in *pxn-1*;*pxn-2* RNAi worms indicated that *pxn-1* and *pxn-2* have an antagonistic relationship in neuronal aging.

*pxn-2* overexpression reduces age-related neuronal defects
-----------------------------------------------------------

To confirm the negative relationship between *pxn-1* and *pxn-2* in neuronal aging, we tested worms overexpressing *pxn-1* and *pxn-2*. We used the following genotypes: *Ppxn-1::pxn-1::gfp*, *Ppxn-2::pxn-2::mCherry*, *Ppxn-1::pxn-1::gfp + Ppxn-2::pxn-2:: mCherry*, and control worms on a *zdIs5* background with the *rol-6* marker. We quantified ALM outgrowth, PLM wavy processes, and PLM branching. There was significantly increased ALM outgrowth on day 15, and PLM wavy processes and branching on days 5 and 15 in *pxn-1* overexpressing worms ([Figs. 3A--3C](#f3-molce-38-8-729){ref-type="fig"}). Interestingly, *pxn-2* overexpression decreased the ALM defects and PLM wavy processes when compared with control worms on day 5 and day 15 ([Figs. 3A and 3B](#f3-molce-38-8-729){ref-type="fig"}). Furthermore, the frequency of wavy neurons in *pxn-2* overexpressing worms on day 15 was similar to that in control worms on day 5.The occurrence of PLM branching in *pxn-2* overexpressing worms was not significantly different from control worms on day 5 or 15 ([Fig. 3C](#f3-molce-38-8-729){ref-type="fig"}). In contrast, *pxn-*1 overexpression showed various PLM defects, including wavy processes, branching, and blebbing (arrows, arrowheads, and open arrow respectively in [Fig. 3D](#f3-molce-38-8-729){ref-type="fig"}) ; therefore, the representative image of PLM defects on day 15 in *pxn-1* overexpressing worms is shown in [Fig. 3D](#f3-molce-38-8-729){ref-type="fig"}. Despite low occurrence of PLM branching, *pxn-1* overexpression dramatically increased defects regardless of time and the type of defects ([Fig. 3C](#f3-molce-38-8-729){ref-type="fig"}). There were no significant differences in ALM or PLM phenotypes in *pxn-1;pxn-2* double overexpressing worms when compared with controls on day 5 and day 15 ([Figs. 3A--3C](#f3-molce-38-8-729){ref-type="fig"}).

*pxn-1* deletion mutation attenuates the age-related decline in short-term memory
---------------------------------------------------------------------------------

According to [@b9-molce-38-8-729] defects in neuronal morphology can indicate both structural and functional neuronal deterioration. Loss of learning and memory is an early recognizable indicator of neuronal aging, followed by chemotaxis and motility loss ([@b9-molce-38-8-729]). We tested short-term memory performance to assess whether the observed morphological defects of neurons reflected a loss of function. We tested the following genotypes: N2 with *gfp* RNAi, *pxn-1* with *gfp*RNAi, N2;*pxn-2 RNAi*, and *pxn-1;pxn-2 RNAi* on days 1, 3, 5, and 7 ([Fig. 4](#f4-molce-38-8-729){ref-type="fig"}). Short-term memory ability was measured via the Chemotaxis response and the results were presented as a massed learning index (LI = CI~Trained~ - CI~Naive~), derived from the observed chemotaxis index \[CI,([@b10-molce-38-8-729])\]. On day 1, all genotypes showed similar LIs. N2 control and *pxn-2* RNAi worms performed slightly better than the other groups, but this was not statistically significant ([Fig. 4](#f4-molce-38-8-729){ref-type="fig"}). N2 control and *pxn-2* RNAi worms showed significant decrease in memory function on day 3 and further decrease on day 5 and 7. However, *pxn-1* mutants consistently showed significantly enhanced performance in the short-term memory test when compared with the control worms from day 3 to day 7. Moreover, *pxn-1*;*pxn-2* RNAi worms showed similar pattern of the N2 decrease in memory function throughout aging, which indicated that the *pxn-1;pxn-2* double deficiency suppressed the effects of the *pxn-1* mutation. These results were consistent with the ALM and PLM neuronal defect results, which further confirm the antagonistic relationship of *pxn-1* with *pxn-2*.

The consistent decrease in short-term memory in all genotypes was comparable to the results in [@b9-molce-38-8-729] suggesting that memory loss is followed by neuronal deterioration ([@b9-molce-38-8-729]). Our results suggested that *pxn-2* is important in neuronal development and aging, and *pxn-1* negatively regulates *pxn-2* function. Moreover, the neuronal defects in both double deficiency and double overexpression conditions were recovered to the level of defects in wild type worms; therefore, the relation between *pxn-1* and *pxn-2* could be important to peroxidasins' function in neuronal development and in aging. In addition, [@b15-molce-38-8-729] have shown that the vascular peroxidasin-like protein (PXDNL), a peroxidasin without peroxidase activity, binds vascular peroxidasin (PXDN) to inhibit peroxidase activity in the human heart ([@b15-molce-38-8-729]). This study suggests that PXN-1 and PXN-2 might interact directly or indirectly to regulate peroxidase activity in *C. elegans*. However, it is possible that *pxn-1* functions independently or there are other master controller(s) that maintain neuronal integrity during aging.
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![*pxn-1* and *pxn-2* double overexpression suppresses the effect of *pxn-1* overexpression in developing neurons. (A) Neuronal defects during development are presented as the percentage of the total number of neurons counted in overexpressing animals: control (*juIs76* \[*Punc-25::gfp*\]), *pxn-1* overexpression (*Ppxn-1::pxn-1*), *pxn-2* overexpression (*Ppxn-2::pxn-2*), and *pxn-*1 and *pxn-2* overexpression (*Ppxn-1::pxn-1*+*Ppxn-2::pxn-2*). (B) Neuronal defects during development are presented as a percentage in various ectopic overexpressing worms: *Phs::gfp*, *pxn-1* overexpression (*Phs::pxn-1*), *pxn-2* overexpression (*Phs::pxn-2*), and *pxn-*1 and *pxn-2* over-expression (*Phs::pxn-1*+*Phs::pxn-2*). All experiments were performed in *juIs76* background. n \> 300 worms per line. Error bar = STD. \**p* \< 0.01; Student's *t*-test.](molce-38-8-729f1){#f1-molce-38-8-729}

![Neuronal defects increase with age. (A, B) A representative image of a mechanosensory neuron ALM, and PLM in a control worm (vector only in *zdIs5*) on day 1, young adult stage. (C--E) Representative ALM and PLM on day 10 (C) and on day 15 (D, E, respectively). The arrowheads indicate a wavy phenotype (C and E) and the arrows represent an outgrowth (C, D). Scale bar = 50 μm. (F, G) ALM outgrowth and PLM wavy neurons are presented as a percentage on days 1, 5, 10, and 15 in control, *pxn-1* mutant (*ok785*), *pxn-2* RNAi treated worms and *pxn-1* treated with *pxn-2* RNAi worms. All experiments were performed in *zdIs5*(*Pmec-4::gfp*) background. n \> 300 worms per line. Error bar = STD. \**p* \< 0.05; \*\**p* \< 0.01; Student's *t*-test.](molce-38-8-729f2){#f2-molce-38-8-729}

![*pxn-1* overexpression exacerbates age-related neuronal defects. (A--C) ALM outgrowth, PLM wavy neurons, and PLM branching in each genotype are presented as a percentage on days 5 and 15 respectively in control (*zdIs5*), *pxn-1* overexpressing, *pxn-2* overexpressing, and *pxn-1* and *pxn-2* overexpressing worms. (D) A representative image of a mechanosensory neuron PLM in a *pxn-1* overexpressing worm on day 5. Arrows and arrowheads represent wavy process and branching respectively. Open arrow represents a blebbing. Scale bar = 50 μm. n \> 300 worms per line. Error bar = STD. \**p* \< 0.05; \*\**p* \< 0.01; Student's *t*-test.](molce-38-8-729f3){#f3-molce-38-8-729}

![Age-related short term memory loss is attenuated in *pxn-1* mutants. The massed learning index (LI) represents a measurement of short term memory and it is calculated by chemotaxis responses. The measurements are performed on day 1, 3, 5, and 7 in control (N2 with *gfp* RNAi), *pxn-1* mutant, N2 with *pxn-2* RNAi treated worms and *pxn-1* treated with *pxn-2* RNAi worms. N \> 300 worms per line. Error bar = STD. \**p* \< 0.05; \*\**p* \< 0.01; Student's *t-*test.](molce-38-8-729f4){#f4-molce-38-8-729}
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